国科微 reported revenue of ¥1.38B for the period ended 2026-06-30, +85.8% year on year. Net income was ¥0.19B, a 13.9% net margin on a 40.6% gross margin. The largest revenue line is 智慧视觉系列产品 at 76% of the total. Free cash flow for the period was ¥0.35B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.38B | +85.8% |
| Gross profit | ¥0.56B | — |
| Operating income | ¥0.22B | — |
| Net income | ¥0.19B | +778.5% |
| Gross margin | 40.6% | Net margin 13.9% |
| Revenue Q/Q | +17.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 智慧视觉系列产品 | ¥1.05B | 75.9% |
| 超高清智能显示系列产品 | ¥0.27B | 19.4% |
| 物联网系列产品 | ¥0.05B | 4.0% |
| 固态存储系列产品 | ¥0.01B | 0.6% |
| 研发设计及服务 | ¥0.00B | 0.1% |
| 其他(补充) | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.82B | 59.4% |
| R&D | ¥0.35B | 25.2% |
| SG&A | ¥0.08B | 6.1% |
| Tax & other | ¥0.03B | 2.0% |
| Item | Amount |
|---|---|
| Total assets | ¥6.68B |
| Total liabilities | ¥2.66B |
| Shareholders' equity | ¥4.02B |
| Equity / assets | 60.2% |
| Operating cash flow | ¥0.46B |
| Capital expenditure | ¥0.12B |
| Free cash flow | ¥0.35B |
| Cash conversion (OCF / net income) | 368% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
佩蒂股份 ・ 宇信科技 ・ 建科院 ・ 华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技 ・ 英搏尔 ・ 朗新科技 ・ 海特生物 ・ 中石科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies